In the early 1960s, in a small shack on the Washington coast, a young, self-educated Japanese scientist performed an experiment to determine what made a certain jellyfish glow. The substance he discovered, green fluorescent protein, would revolutionize molecular biology, transforming our study of everything from the AIDS virus to the workings of the brain. Aglow in the Dark follows the path that took this glowing compound from its inauspicious arrival on the scientific scene to its present-day eminence as one of the most groundbreaking discoveries of the twentieth century.
The story unfolds in far-flung places, from the coral reefs of the Pacific Ocean, to the medical schools and marine stations of our leading universities, to a cold war-era research laboratory in Moscow. Traversing the globe and the decades, Aglow in the Dark conveys the human fascination with bioluminescence, or "living light," its little-known application in war, forensic science, and molecular biology, and how it led to the finding of green fluorescent protein. The book reveals a hidden world where light is manipulated by animals and humans and put to remarkable uses--unlocking the secrets of the human brain, conquering dreaded diseases, and perhaps someday linking minds and machines. The authors deftly lead the reader through a complex story at the interface of biology and physics--and into the realm of wonder on the frontiers of scientific endeavor.
A leading bioethicist offers critical insights into the scientific, ethical, and political implications of human genome editing.
Designer babies, once found only in science fiction, have become a reality. We are entering a new era of human evolution with the advent of a technology called CRISPR, which allows scientists to modify our genes. Although CRISPR shows great promise for therapeutic use, it raises thorny ethical, legal, political, and societal concerns because it can be used to make permanent changes to future generations. What if changes intended for the good turn out to have unforeseen negative effects? What if the divide between the haves and have-nots widens as a result? Who decides whether we genetically modify human beings and, if so, how?
Françoise Baylis insists that we must all have a role in determining our future as a species. The scientists who develop and use genome-editing tools should not be the only ones making decisions about future uses of the technology. Such decisions must be the fruit of a broad societal consensus. Baylis argues that it is in our collective interest to assess and steer the development and implementation of biomedical technologies. Members of the public with different interests and diverse perspectives must be among the decision makers; only in this way can we ensure that societal concerns are taken into account and that responsible decisions are made. We must be engaged and informed, think critically, and raise our voices as we create our future together.
Sharp, rousing, timely, and thought-provoking, Altered Inheritance is essential reading. The future of humanity is in our hands.
Contributors
Vincanne Adams
Nancy N. Chen
Stefan Ecks
Kathleen Erwin
Phuoc V. Le
Jennifer Liu
Aihwa Ong
Margaret Sleeboom-Faulkner
Kaushik Sunder Rajan
Wen-Ching Sung
Charis Thompson
Ara Wilson
Fighting disease, combating hunger, preserving the balance of life on Earth: the future of biotechnological innovation may well be the future of our planet itself. And yet the vexed state of intellectual property law—a proliferation of ever more complex rights governing research and development—is complicating this future. At a similar point in the development of information technology, “open source” software revolutionized the field, simultaneously encouraging innovation and transforming markets. The question that Janet Hope explores in Biobazaar is: can the open source approach do for biotechnology what it has done for information technology? Her book is the first sustained and systematic inquiry into the application of open source principles to the life sciences.
The appeal of the open source approach—famously likened to a “bazaar,” in contrast to the more traditional “cathedral” style of technology development—lies in its safeguarding of community access to proprietary tools without discouraging valuable commercial participation. Traversing disciplinary boundaries, Hope presents a careful analysis of intellectual property-related challenges confronting the biotechnology industry and then paints a detailed picture of “open source biotechnology” as a possible solution. With insights drawn from interviews with Nobel Prize–winning scientists and leaders of the free and open source software movement—as well as company executives, international policymakers, licensing experts, and industry analysts—her book suggests that open source biotechnology is both desirable and broadly feasible—and, in many ways, merely awaiting its moment.
Sunder Rajan’s ethnography informs his theoretically sophisticated inquiry into how the contemporary world is shaped by the marriage of biotechnology and market forces, by what he calls technoscientific capitalism. Bringing Marxian theories of value into conversation with Foucaultian notions of biopolitics, he traces how the life sciences came to be significant producers of both economic and epistemic value in the late twentieth century and early twenty-first.
Technology is a process and a body of knowledge as much as a collection of artifacts. Biology is no different—and we are just beginning to comprehend the challenges inherent in the next stage of biology as a human technology. It is this critical moment, with its wide-ranging implications, that Robert Carlson considers in Biology Is Technology. He offers a uniquely informed perspective on the endeavors that contribute to current progress in this area—the science of biological systems and the technology used to manipulate them.
In a number of case studies, Carlson demonstrates that the development of new mathematical, computational, and laboratory tools will facilitate the engineering of biological artifacts—up to and including organisms and ecosystems. Exploring how this will happen, with reference to past technological advances, he explains how objects are constructed virtually, tested using sophisticated mathematical models, and finally constructed in the real world.
Such rapid increases in the power, availability, and application of biotechnology raise obvious questions about who gets to use it, and to what end. Carlson’s thoughtful analysis offers rare insight into our choices about how to develop biological technologies and how these choices will determine the pace and effectiveness of innovation as a public good.
Contributors. Natalie Boero, Adele E. Clarke, Jennifer R. Fishman, Jennifer Ruth Fosket, Kelly Joyce, Jonathan Kahn, Laura Mamo, Jackie Orr, Elianne Riska, Janet K. Shim, Sara Shostak
Some of humankind's greatest tools have been forged in the research laboratory. Who could argue that medical advances like antibiotics, blood transfusions, and pacemakers have not improved the quality of people's lives? But with each new technological breakthrough there comes an array of consequences, at once predicted and unpredictable, beneficial and hazardous.
Outcry over recent developments in the reproductive and genetic sciences has revealed deep fissures in society's perception of biotechnical progress. Many are concerned that reckless technological development, driven by consumerist impulses and greedy entrepreneurialism, has the potential to radically shift the human condition—and not for the greater good. Biotechnology and the Human Good builds a case for a stewardship deeply rooted in Judeo-Christian theism to responsibly interpret and assess new technologies in a way that answers this concern.
The authors jointly recognize humans not as autonomous beings but as ones accountable to each other, to the world they live in, and to God. They argue that to question and critique how fields like cybernetics, nanotechnology, and genetics might affect our future is not anti-science, anti-industry, or anti-progress, but rather a way to promote human flourishing, common sense, and good stewardship.
A synthetic work drawing on the thought of a physician, ethicists, and a theologian, Biotechnology and the Human Good reminds us that although technology is a powerful and often awe-inspiring tool, it is what lies in the heart and soul of who wields this tool that truly makes the difference in our world.
In this masterful account, a historian of science surveys the molecular biology revolution, its origin and continuing impact.
Since the 1930s, a molecular vision has been transforming biology. Michel Morange provides an incisive and overarching history of this transformation, from the early attempts to explain organisms by the structure of their chemical components, to the birth and consolidation of genetics, to the latest technologies and discoveries enabled by the new science of life. Morange revisits A History of Molecular Biology and offers new insights from the past twenty years into his analysis.
The Black Box of Biology shows that what led to the incredible transformation of biology was not a simple accumulation of new results, but the molecularization of a large part of biology. In fact, Morange argues, the greatest biological achievements of the past few decades should still be understood within the molecular paradigm. What has happened is not the displacement of molecular biology by other techniques and avenues of research, but rather the fusion of molecular principles and concepts with those of other disciplines, including genetics, physics, structural chemistry, and computational biology. This has produced decisive changes, including the discoveries of regulatory RNAs, the development of massive scientific programs such as human genome sequencing, and the emergence of synthetic biology, systems biology, and epigenetics.
Original, persuasive, and breathtaking in its scope, The Black Box of Biology sets a new standard for the history of the ongoing molecular revolution.
Developments in biotechnology, such as cloning and the decoding of the human genome, are generating questions and choices that traditionally have fallen within the realm of religion and philosophy: the definition of human life, human vs. divine control of nature, the relationship between human and non-human life, and the intentional manipulation of the mechanisms of life and death.
In Claiming Power over Life, eight contributors challenge policymakers to recognize the value of religious views on biotechnology and discuss how best to integrate the wisdom of the Christian and Jewish traditions into public policy debates. Arguing that civic discourse on the subject has been impoverished by an inability to accommodate religious insights productively, they identify the ways in which religious thought can contribute to policymaking. Likewise, the authors challenge religious leaders and scholars to learn about biotechnology, address the central issues it raises, and participate constructively in the moral debates it engenders.
The book will be of value to policymakers, religious leaders, ethicists, and all those interested in issues surrounding the intersection of religion and biotechnology policy.
Biotechnology crop production area increased from 1.7 million hectares to 148 million hectares worldwide between 1996 to 2010. While genetically modified food is a contentious issue, the debates are usually limited to health and environmental concerns, ignoring the broader questions of social control that arise when food production methods become corporate-owned intellectual property. Drawing on legal documents and dozens of interviews with farmers and other stakeholders, Corporate Crops covers four case studies based around litigation between biotechnology corporations and farmers. Pechlaner investigates the extent to which the proprietary aspects of biotechnologies—from patents on seeds to a plethora of new rules and contractual obligations associated with the technologies—are reorganizing crop production.
The lawsuits include patent infringement litigation launched by Monsanto against a Saskatchewan canola farmer who, in turn, claimed his crops had been involuntarily contaminated by the company’s GM technology; a class action application by two Saskatchewan organic canola farmers launched against Monsanto and Aventis (later Bayer) for the loss of their organic market due to contamination with GMOs; and two cases in Mississippi in which Monsanto sued farmers for saving seeds containing its patented GM technology. Pechlaner argues that well-funded corporate lawyers have a decided advantage over independent farmers in the courts and in creating new forms of power and control in agricultural production. Corporate Crops demonstrates the effects of this intersection between the courts and the fields where profits, not just a food supply, are reaped.
After Fidel Castro came to power in 1959, his second declaration, after socialism, was that Cuba would become a leader in international science. In biotechnology he would be proven right and, today, Cuba counts a meningitis B vaccine and cutting-edge cancer therapies to its name. But how did this politically and geographically isolated country make such impressive advances? Drawing on a unique ethnography, and blending the insights of anthropology, sociology, and geography, The Cuban Cure shows how Cuba came to compete with U. S. pharmaceutical giants—despite a trade embargo and crippling national debt.
In uncovering what is distinct about Cuban biomedical science, S. M. Reid-Henry examines the forms of resistance that biotechnology research in Cuba presents to the globalization of western models of scientific culture and practice. He illustrates the epistemic, social, and ideological clashes that take place when two cultures of research meet, and how such interactions develop as political and economic circumstances change. Through a novel argument about the intersection of socioeconomic systems and the nature of innovation, The Cuban Cure presents an illuminating study of politics and science in the context of globalization.
How did cells make the journey, one we take so much for granted, from their origin in living bodies to something that can be grown and manipulated on artificial media in the laboratory, a substantial biomass living outside a human body, plant, or animal? This is the question at the heart of Hannah Landecker's book. She shows how cell culture changed the way we think about such central questions of the human condition as individuality, hybridity, and even immortality and asks what it means that we can remove cells from the spatial and temporal constraints of the body and "harness them to human intention."
Rather than focus on single discrete biotechnologies and their stories--embryonic stem cells, transgenic animals--Landecker documents and explores the wider genre of technique behind artificial forms of cellular life. She traces the lab culture common to all those stories, asking where it came from and what it means to our understanding of life, technology, and the increasingly blurry boundary between them. The technical culture of cells has transformed the meaning of the term "biological," as life becomes disembodied, distributed widely in space and time. Once we have a more specific grasp on how altering biology changes what it is to be biological, Landecker argues, we may be more prepared to answer the social questions that biotechnology is raising.
“Will the future confront us with human GMOs? Greely provocatively declares yes, and, while clearly explaining the science, spells out the ethical, political, and practical ramifications.”—Paul Berg, Nobel Laureate and recipient of the National Medal of Science
Within twenty, maybe forty, years most people in developed countries will stop having sex for the purpose of reproduction. Instead, prospective parents will be told as much as they wish to know about the genetic makeup of dozens of embryos, and they will pick one or two for implantation, gestation, and birth. And it will be safe, lawful, and free. In this work of prophetic scholarship, Henry T. Greely explains the revolutionary biological technologies that make this future a seeming inevitability and sets out the deep ethical and legal challenges humanity faces as a result.
“Readers looking for a more in-depth analysis of human genome modifications and reproductive technologies and their legal and ethical implications should strongly consider picking up Greely’s The End of Sex and the Future of Human Reproduction… [It has] the potential to empower readers to make informed decisions about the implementation of advancements in genetics technologies.”
—Dov Greenbaum, Science
“[Greely] provides an extraordinarily sophisticated analysis of the practical, political, legal, and ethical implications of the new world of human reproduction. His book is a model of highly informed, rigorous, thought-provoking speculation about an immensely important topic.”
—Glenn C. Altschuler, Psychology Today
The alarm calls of birds make them difficult for predators to locate, while the howl of wolves and the croak of bullfrogs are designed to carry across long distances. From an engineer's perspective, how do such specialized adaptations among living things really work? And how does physics constrain evolution, channeling it in particular directions?
Writing with wit and a richly informed sense of wonder, Denny and McFadzean offer an expert look at animals as works of engineering, each exquisitely adapted to a specific manner of survival, whether that means spinning webs or flying across continents or hunting in the dark-or writing books. This particular book, containing more than a hundred illustrations, conveys clearly, for engineers and nonengineers alike, the physical principles underlying animal structure and behavior.
Pigeons, for instance-when understood as marvels of engineering-are flying remote sensors: they have wideband acoustical receivers, hi-res optics, magnetic sensing, and celestial navigation. Albatrosses expend little energy while traveling across vast southern oceans, by exploiting a technique known to glider pilots as dynamic soaring. Among insects, one species of fly can locate the source of a sound precisely, even though the fly itself is much smaller than the wavelength of the sound it hears. And that big-brained, upright Great Ape? Evolution has equipped us to figure out an important fact about the natural world: that there is more to life than engineering, but no life at all without it.
Recent decades have seen tremendous changes in Latin America's agricultural sector, resulting from a broad program of liberalization instigated under pressure from the United States, the IMF, and the World Bank. Tariffs have been lifted, agricultural markets have been opened and privatized, land reform policies have been restricted or eliminated, and the perspective has shifted radically toward exportation rather than toward the goal of feeding local citizens. Examining the impact of these transformations, the contributors to Food for the Few: Neoliberal Globalism and Biotechnology in Latin America paint a somber portrait, describing local peasant farmers who have been made responsible for protecting impossibly vast areas of biodiversity, or are forced to specialize in one genetically modified crop, or who become low-wage workers within a capitalized farm complex. Using dozens of examples such as these, the deleterious consequences are surveyed from the perspectives of experts in diverse fields, including anthropology, economics, geography, political science, and sociology.
From Kathy McAfee's "Exporting Crop Biotechnology: The Myth of Molecular Miracles," to Liz Fitting's "Importing Corn, Exporting Labor: The Neoliberal Corn Regime, GMOs, and the Erosion of Mexican Biodiversity," Food for the Few balances disturbing findings with hopeful assessments of emerging grassroots alternatives. Surveying not only the Latin American conditions that led to bankruptcy for countless farmers but also the North's practices, such as the heavy subsidies implemented to protect North American farmers, these essays represent a comprehensive, keenly informed response to a pivotal global crisis.
Contributors discuss alternatives to the programmatic view of dna, including the developmental systems approach, methodical culturalism, the molecular process concept of the gene, the hermeneutic theory of description, and process structuralist biology. None of the approaches cast doubt on the notion that dna is tremendously important to biological life on earth; rather, contributors examine different ideas of how dna should be represented, evaluated, and explained. Just as ideas about genetic codes have reached far beyond the realm of science, the reconceptualizations of genetic theory in this volume have broad implications for ethics, philosophy, and the social sciences.
Contributors. Thomas Bürglin, Brian C. Goodwin, James Griesemer, Paul Griffiths, Jesper Hoffmeyer, Evelyn Fox Keller, Gerd B. Müller, Eva M. Neumann-Held, Stuart A. Newman, Susan Oyama, Christoph Rehmann-Sutter, Sahotra Sarkar, Jackie Leach Scully, Gerry Webster, Ulrich Wolf
Drawing on archival materials of twentieth-century biology; little-known works of fiction and science fiction; and twentieth- and twenty-first century U.S. and U.K. government reports by the National Institutes of Health, the Parliamentary Advisory Group on the Ethics of Xenotransplantation, and the President’s Council on Bioethics, she examines a number of biomedical changes as each was portrayed by scientists, social scientists, and authors of fiction and poetry. Among the scientific developments she considers are the cultured cell, the hybrid embryo, the engineered intrauterine fetus, the child treated with human growth hormone, the process of organ transplantation, and the elderly person rejuvenated by hormone replacement therapy or other artificial means. Squier shows that in the midst of new phenomena such as these, literature helps us imagine new ways of living. It allows us to reflect on the possibilities and perils of our liminal lives.
Contributors. Timothy Choy, Joseph Dumit, Michael M. J. Fischer, Kim Fortun, Mike Fortun, Donna Haraway, Sheila Jasanoff, Wen-Hua Kuo, Andrew Lakoff, Kristin Peterson, Chloe Silverman, Elta Smith, Kaushik Sunder Rajan, Travis J. Tanner
Kermit the Frog famously said that it isn’t easy being green, and in Living at Micro Scale David Dusenbery shows that it isn’t easy being small—existing at the size of, say, a rotifer, a tiny multicellular animal just at the boundary between the visible and the microscopic. “Imagine,” he writes, “stepping off a curb and waiting a week for your foot to hit the ground.” At that scale, we would be small enough to swim inside the letter O in the word “rotifer.” What are the physical consequences of life at this scale? How do such organisms move, identify prey and predators and (if they’re so inclined) mates, signal to one another, and orient themselves?
In clear and engaging prose, Dusenbery uses straightforward physics to demonstrate the constraints on the size, shape, and behavior of tiny organisms. While recounting the historical development of the basic concepts, he unearths a corner of microbiology rich in history, and full of lessons about how science does or does not progress. Marshalling findings from different fields to show why tiny organisms have some of the properties they are found to have, Dusenbery shows a science that doesn’t always move triumphantly forward, and is dependent to a great extent on accident and contingency.
How capitalism is reconfiguring the very texture of life
Mutant Ecologies traces the spinning of new synthetic threads into the web of life. It is a critical cartography of the shifting landscapes of capital accumulation conjured by recent developments in genomic science, genome editing, and the biotech industry.
CRISPR crops, fast-growing salmons, heat-resistant Slick™ cows, Friendly™ Mosquitoes, humanized mice, pigs growing human organs – these are but a few of the dazzling new life-forms that have recently emerged from corporate and university laboratories around the world, all promising to lubricate the circuits of capital accumulation in distinct ways. The deliberate induction of genetic mutations is increasingly central to business operations in a number of sectors, from agriculture to pharmaceuticals.
While the Nobel Committee recently proclaimed the life sciences to have entered 'a new epoch', the authors show how these technological innovations continue to operate within a socio-historical context defined by the iron rules of capitalist competition and exploitation. Capital no longer contents itself by simply appropriating the living bodies of plants and animals. It purposefully designs its internal metabolism, and in that way, it redesigns the countless living vectors that constitute the global biosphere. It is driving a biological revolution, which will ripple through the everyday lives of people everywhere.
A Primer for Computational Biology aims to provide life scientists and students the skills necessary for research in a data-rich world. The text covers accessing and using remote servers via the command-line, writing programs and pipelines for data analysis, and provides useful vocabulary for interdisciplinary work. The book is broken into three parts:
Microchips. Genetic modification of plants. Cloning. Advances in technology promise to shape our lives more profoundly than ever before. Exciting new discoveries in reproductive, genetic, and information technologies all serve to call into question the immutability of the boundaries between humans, animals, and machines. The category of the “posthuman” reflects the implications of such new technologies on contemporary culture, especially in their capacity to reconfigure the human body and to challenge our most fundamental understandings of human nature.
Elaine L. Graham explores these issues as they are expressed within popular culture and the creative arts. From the myth of Prometheus and the Gothic horror of Frankenstein’s monster to contemporary postmodern science fiction, a gallery of fantastic creatures haunts Western myth, religion, and literature. They serve to connect contemporary debates with enduring concerns about the potential—and the limits—of human creativity.
This book breaks new ground in drawing together a wide range of literature on new technologies and their ethical implications. In her explorations of the monstrous and the cyborg, Graham covers the Jewish legend of the golem, the Human Genome Project, Star Trek: Next Generation, Star Trek: Voyager, Fritz Lang’s Metropolis, Donna Haraway’s cyborg writing, andmany other related topics. This book will interest students in cultural studies, literature, ethics, religion, information technology, and the life sciences.
With scientific progress occurring at a breathtaking pace, science and technology policy has never been more important than it is today. Yet there is a very real lack of public discourse about policy-making, and government involvement in science remains shrouded in both mystery and misunderstanding. Who is making choices about technology policy, and who stands to win or lose from these choices? What criteria are being used to make decisions and why? Does government involvement help or hinder scientific research?
Shaping Science and Technology Policy brings together an exciting and diverse group of emerging scholars, both practitioners and academic experts, to investigate current issues in science and technology policy. Essays explore such topics as globalization, the shifting boundary between public and private, informed consent in human participation in scientific research, intellectual property and university science, and the distribution of the costs and benefits of research.
Contributors: Charlotte Augst, Grant Black, Mark Brown, Kevin Elliott, Patrick Feng, Pamela M. Franklin, Carolyn Gideon, Tené N. Hamilton, Brian A. Jackson, Shobita Parthasarathy, Jason W. Patton, A. Abigail Payne, Bhaven Sampat, Christian Sandvig, Sheryl Winston Smith, Michael Whong-Barr
Listen to a short interview with Robert PaarlbergHost: Chris Gondek | Producer: Heron & Crane
Heading upcountry in Africa to visit small farms is absolutely exhilarating given the dramatic beauty of big skies, red soil, and arid vistas, but eventually the two-lane tarmac narrows to rutted dirt, and the journey must continue on foot. The farmers you eventually meet are mostly women, hardworking but visibly poor. They have no improved seeds, no chemical fertilizers, no irrigation, and with their meager crops they earn less than a dollar a day. Many are malnourished.
Nearly two-thirds of Africans are employed in agriculture, yet on a per-capita basis they produce roughly 20 percent less than they did in 1970. Although modern agricultural science was the key to reducing rural poverty in Asia, modern farm science—including biotechnology—has recently been kept out of Africa.
In Starved for Science Robert Paarlberg explains why poor African farmers are denied access to productive technologies, particularly genetically engineered seeds with improved resistance to insects and drought. He traces this obstacle to the current opposition to farm science in prosperous countries. Having embraced agricultural science to become well-fed themselves, those in wealthy countries are now instructing Africans—on the most dubious grounds—not to do the same.
In a book sure to generate intense debate, Paarlberg details how this cultural turn against agricultural science among affluent societies is now being exported, inappropriately, to Africa. Those who are opposed to the use of agricultural technologies are telling African farmers that, in effect, it would be just as well for them to remain poor.
The timeless human desire to be more beautiful, intelligent, healthy, athletic, or young has given rise in our time to technologies of human enhancement. Athletes use drugs to increase their strength or stamina; cosmetic surgery is widely used to improve physical appearance; millions of men take drugs like Viagra to enhance sexual performance. And today researchers are exploring technologies such as cell regeneration and implantable devices that interact directly with the brain. Some condemn these developments as a new kind of cheating—not just in sports but in life itself—promising rewards without effort and depriving us most of all of what it means to be authentic human beings. “Transhumanists,” on the other hand, reject what they see as a rationalizing of human limits, as if being human means being content forever with underachieving bodies and brains. To be human, they insist, is to be restless with possibilities, always eager to transcend biological limits.
As the debate grows in urgency, how should theology respond? Christian theologians recognize truth on both sides of the argument, pointing out how the yearnings of the transhumanists—if not their technological methods—find deep affinities in Christian belief. In this volume, Ronald Cole-Turner has joined seasoned scholars and younger, emerging voices together to bring fresh insight into the technologies that are already reshaping the future of Christian life and hope.
With genetically modified crops we have entered uncharted territory—where visions of the triumph of biotechnology in agriculture vie with dire views of medical and environmental disaster. For two years Mark L. Winston traveled this fraught territory at home and abroad, listening to farmers, industry spokespeople, regulators, and researchers, canvassing high-security laboratories, environmentalist enclaves, and cyberspace, making a thorough survey of the facts, opinions, and practices deployed by opponents and proponents of transgenic crops.
Through his sympathetic portrayal of the passions on all sides, Winston brings a clear, unbiased perspective to this bewildering landscape. Traveling with Winston, we see the excitement and curiosity that pervade laboratories developing genetically modified crops, as well as the panic and outrage among dedicated opponents of agricultural biotechnology; the desperation of conventional farmers as they look to science for solutions to the problems driving them from their farms, as well as the deeply held values of organic farmers who dread the incursion of genetically modified crops into their expanding enterprise. And, Winston shows us, these contrasting attitudes transcend national borders, with troubling counterparts and consequences in the developing world.
As he seeks a middle ground where concerns about genetic engineering can be rationally discussed and resolved, Winston gives us, at long last, a full and balanced view of the forces at play in the chaotic debate over agricultural biotechnology.
READERS
Browse our collection.
PUBLISHERS
See BiblioVault's publisher services.
STUDENT SERVICES
Files for college accessibility offices.
UChicago Accessibility Resources
home | accessibility | search | about | contact us
BiblioVault ® 2001 - 2024
The University of Chicago Press